Times Asia Edition对 今又生 研究及上市情况的简要报道

2006年10月23日Times Asia Edition对 今又生 研究及上市的的报道

原文连接：http://www.time.com/time/asia/covers/501061030/profiles.html

相关连接（这个也很有意思）：http://www.time.com/time/asia/~undefined*~Lyes~Kbr_~H~M~2~1~Kbr_~H~M~2~1Groundbreakers~Kbr_~H~M~2~1~Kbr_~H~M~2~1~Kbr_~H~M~2~1From_biotech_to_nanotech~E_three_Chinese_pioneers_look_to_lead_the_nation_to_a_new_scientific_frontier~Kbr_~H~M~2~1~Kbr_~H~M~2~1By_Hannah_Beech_~V_Shenyang~Kbr_~H~M~2~1~Kbr_~H~M~2~1Posted_Monday~E_October_23~E_2006~J_20~I00_HKT~Kbr_~H~M~2~1Nowhere_is_Asia~9s_scientific_revolution_unfolding_more_dramatically_than_in_China~E_where_researchers_are_taking_advantage_of_bounteous_funds_and_pushing_hard_to_fulfill_a_government_mandate_to_innovate._Here_are_three_Chinese_scientists_whose_discoveries_in_the_emerging_biotech_and_nanotech_fields_could_transform_the_way_we_live_and_help_secure_China~9s_position_as_a_scientific_superpower~I~Kbr_~H~M~2~1~Kbr_~H~M~2~1PENG_ZHAOHUI~Kbr_~H~M~2~1Gene_Healing~Kbr_~H~M~2~1In_1998~E_Chinese_molecular_biologist_Peng_Zhaohui_left_the_safe_confines_of_San_Diego~E_where_he_had_worked_for_several_years~E_for_a_newly_built_science_park_in_the_southern_Chinese_boomtown_of_Shenzhen._His_immodest_goal~I_to_create_a_gene~Ftherapy_medication_that_would_save_many_lives._Five_years_and_$6.25_million_in_government_seed_money_later~E_the_firm_Peng_founded~E_Shenzhen_SiBiono_GeneTech_Co.~E_became_the_first_corporation_in_the_world_to_be_granted_a_license_for_a_gene~Ftherapy_treatment._Called_Gendicine~E_the_drug_aims_to_combat_different_types_of_cancer_by_injecting_a_virus_laced_with_a_tumor~Fsuppressing_gene_into_the_human_body._By_the_end_of_2005~E_more_than_3~E500_Chinese_and_foreign_patients_had_been_treated_for_43_types_of_cancer_with_the_$1~E700~Fper~Fdose_treatment._~AA_course_typically_requires_at_least_six_doses.~B_Peng_says_that_combining_radiation_and_chemotherapy_with_Gendicine_is_three_times_more_effective_than_just_using_the_traditional_cancer_treatments._~4Westerners_never_imagined_that_the_world~9s_first_gene~Ftherapy_medication_would_come_from_China~E~4_he_says._~4But_if_they_had_been_watching_what_was_happening_in_China~E_they_might_not_have_been_so_surprised.~4~Kbr_~H~M~2~1~Kbr_~H~M~2~1Gendicine~9s_success_is_due_in_part_to_China~9s_relatively_relaxed_regulatory_environment._American_biotech_firm_Introgen~E_which_has_developed_rival_technology_to_that_used_by_SiBiono~E_is_still_awaiting_regulatory_approval_in_the_U.S._after_undergoing_exhaustive_clinical_trials_for_its_gene~Ftherapy_drug._Testing_can_easily_take_a_decade_in_the_U.S.~E_but_SiBiono_accomplished_it_in_just_six_years._Moreover~E_the_trials_cost_SiBiono_just_$2~E500_per_patient~E_compared_to_around_$100~E000_per_person_in_America._The_possibly_looser_rules_and_comparative_lack_of_transparency_surrounding_Gendicine~9s_approval_by_the_Chinese_Food_and_Drug_Administration_have_prompted_criticism_that_SiBiono_may_not_have_adequately_tested_the_long~Fterm_effects_of_its_treatment._Peng~9s_efficacy_claims_have_not_been_internationally_verified_but_he_insists_that_tests_have_confirmed_the_drug_is_safe_and_effective._Meanwhile~E_enthusiasm_for_gene_therapy_has_chilled_somewhat_in_the_U.S.~E_after_a_patient_died_during_clinical_trials_of_another_gene~Ftherapy_drug_in_1999._Still~E_Peng_is_hopeful_that_Gendicine~9s_licensing_will_help_catapult_China_into_the_top_ranks_of_this_emerging_field._Already~E_the_country~9s_gene~Ftherapy_guidelines_are_being_used_as_a_model_by_other_nations_publishing_their_own_quality~Fcontrol_regulations._~4If_SiBiono_helps_China_become_a_leader_in_biopharma~E~4_says_Peng~E_~4I_will_be_quite_proud.~4